The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
100 years of the Warburg effect: A cancer metabolism endeavor
Open accessAbstract
If you are a scientist and you only know one thing about tumor metabolism, it's likely the Warburg effect. But who was Otto Warburg, and how did his discoveries regarding the metabolism of tumors shape our current thinking about the metabolic needs of cancer cells?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accumulating evidence has demonstrated a close association between glycolytic activity and tumor cell proliferation, survival, and disease progression across multiple cancer types (27).”
From Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma (2026) · cites this paper as [27]
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Kalos, M. D., Levine, B. L., Porter, D. L., Katz, S. I., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,417
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
Connecting copper and cancer: from transition metal signalling to metalloplasia
Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S. K., et al. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,332
Flagged first, then by citations
1 of the 53 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Krebs, 1972, Otto Heinrich Warburg, 1883-1970, Biogr. Mem. Fellows R. Soc., 18, 629
Cited by
Sorted by citations
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 484
Mitochondrial metabolism and cancer therapeutic innovation
Du, H., Xu, T., Yu, S., Wu, S., & Zhang, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02311-x · Cited by 283
Cross-priming in cancer immunology and immunotherapy
Luri‐Rey, C., Teijeira, Á., Wculek, S. K., de Andrea, C. E., Herrero, C., López‐Janeiro, Á., Rodriguez-Ruiz, M. E., Heras‐Murillo, I., Aggelakopoulou, M., Berraondo, P., et al. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00785-5 · Cited by 150
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 138
Cancer stem cells and niches: challenges in immunotherapy resistance
Pan, Y., Yuan, C., Zeng, C., Sun, C., Xia, L., Wang, G., Chen, X., Zhang, B., Liu, J., & Ding, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02265-2 · Cited by 117
Clinical approaches to overcome PARP inhibitor resistance
Zou, Y., Zhang, H., Chen, P., Tang, J., Yang, S., Nicot, C., Guan, Z., Li, X., & Tang, H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02355-1 · Cited by 118
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Ma, Q., Zhang, W., Wu, K., & Shi, L. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02218-1 · Cited by 101
mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics
Zhang, H., Xiao, X., Pan, Z., & Dokudovskaya, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02493-4 · Cited by 94
Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Ricci, J. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115206 · Cited by 73
Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
Lanzetti, L. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01402-6 · Cited by 57
Acidosis orchestrates adaptations of energy metabolism in tumors
Groessl, S., Kalis, R., Snaebjornsson, M. T., Wambach, L., Haider, J., Andersch, F., Schulze, A., Palm, W., & Zuber, J. A. (2025) · Science · doi:10.1126/science.adp7603 · Cited by 58
Wang, X., Luo, X., Xiao, R., Liu, X., Zhou, F., Jiang, D., Bai, J., Cui, M., You, L., & Yupei, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02334-4 · Cited by 59
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 52
Ji, X., & Xia, L. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00719-3 · Cited by 57
The role and mechanism of fatty acid oxidation in cancer drug resistance
Lei, Y., Cai, S., Zhang, J., Ding, S., Zhang, Z.-H., Zhang, C., Dai, D., & Li, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02554-1 · Cited by 51
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
Choate, K. A., Pratt, E. P. S., Jennings, M. J., Winn, R. J., & Mann, P. B. (2024) · Biology · doi:10.3390/biology13110885 · Cited by 49
Luo, L., Zhuang, X., Fu, L., Dong, Z., Yi, S., Wang, K., Jiang, Y., Zhao, J., Yang, X., & Hei, F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70098 · Cited by 38
Zhang, Z., Tang, S., Qi, M., Zhao, H., Wu, M., & Huang, S. (2025) · Theranostics · doi:10.7150/thno.107812 · Cited by 30
Lactylation in cancer biology: Unlocking new avenues for research and therapy
Hou, X., Hong, Z., Zeng, H., Zhang, C., Zhang, P., Ma, D., & Han, Z. (2025) · 癌症:英文版 · doi:10.1002/cac2.70054 · Cited by 39
Glioma stem cells: drivers of tumor progression and recurrence
He, J., Yan, X., & Hu, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04352-z · Cited by 34
Deng, X., Wu, D., Zhao, Y., Qing, Y., Wu, H., & Chen, J. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.12.001 · Cited by 28
Metabolic adaptations in cancer progression
Peng‐Winkler, Y., & Fendt, S. (2025) · Physiological Reviews · doi:10.1152/physrev.00037.2024 · Cited by 25
Self-citationZhang, B., Xu, A., Wang, H., Yan, W., Zhang, Q., & Wang, S. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05881-9 · Cited by 27
Liu, Q., Li, J., Li, X., Zhang, L., Yao, S., Wang, Y., Tuo, B., & Jin, H. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5429 · Cited by 24
Jiang, C.-F., Qian, Y.-C., Bai, X., Li, S., Zhang, L., Xie, Y.-X., Lu, Y.-F., Lu, Z.-M., Liu, B., & Jiang, B. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217612 · Cited by 22
Mathan, S. V., & Singh, R. P. (2025) · Cancers · doi:10.3390/cancers17132100 · Cited by 24
Metabolic reprogramming in cancer: signaling pathways and therapeutic targets
Dong, S., & Lei, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02582-0 · Cited by 31
Lin, Z., Long, F., Liu, J., Kang, R., Klionsky, D. J., Kroemer, G., Tang, D., & Yang, M. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02392-w · Cited by 24
Role of gut microbiome in suppression of cancers
Xu, Y., Gao, Z., Liu, J., Yang, Q., & Xu, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2495183 · Cited by 21
Yuan, Q., Sha, Y., Ye, R., Hao, Y., Ni, L., Han, J., & Lin, D. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07555-3 · Cited by 19
Unraveling the nexus: Genomic instability and metabolism in cancer
Gujar, V. V., Li, H., Paull, T. T., Neumann, C. A., & Weyemi, U. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115540 · Cited by 21
Exploiting metabolic vulnerabilities in cancer: From mechanisms to therapeutic opportunities
Xue, Z.-R., Xin, Y.-Y., & Jin, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218067 · Cited by 21
Targeting mitochondrial structure and dynamics for therapeutic intervention in cancer
Iwata, W., Haggerty, N., Sesaki, H., & Iijima, M. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003453 · Cited by 19
Tang, S., Liu, Y., Jin, B., Zhang, T., Wang, X., Zhao, J., Xu, Z., Zhao, W., Bian, H., Li, K., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117553 · Cited by 18
The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications
Liu, Y., Hu, P., Cheng, H., Xu, F., & Ye, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1514394 · Cited by 17
Single‐Cell Insights Into Macrophage Subtypes in Pulmonary Infections
Lin, Z., Zheng, Y., Zhong, Y., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510758 · Cited by 13
Yu, K., Sun, J., Zhang, J., Shi, Y., Wang, J., Wu, Y., Lu, D., Niu, X., Li, Y., Huang, S., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218282 · Cited by 13
Oxidative Stress in the Tumor Immune Microenvironment: Mechanisms and Therapeutic Perspectives
Wang, Z., Li, B., Tang, P., Yan, F., Wang, S., Leng, G., Dawa, P., Chen, Y., Guo, Y., Yang, P., et al. (2026) · MedComm – Oncology · doi:10.1002/mog2.70068 · Cited by 14
Endoplasmic reticulum stress on glioblastoma: Tumor growth promotion and immunosuppression
Yang, L., Xue, R., Yang, C., Lv, Y., Li, S., Xiang, W., Guo, X., & Zhou, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114806 · Cited by 12
Emerging roles of angiopoietin‑like 4 in human tumors (Review)
Liu, R., Fu, M., Chen, P., Liu, Y., Huang, W., Sun, X., Zhu, P., Wen, Z., & Cheng, Y. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5715 · Cited by 12
Metabolite to Modifier: Lactate and Lactylation in the Evolution of Tumors
Zhao, L., Cui, H., Li, Y., Ye, Y., & Shen, Z. (2025) · MedComm · doi:10.1002/mco2.70413 · Cited by 11
Immunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
Gong, N., Pan, X., Deng, Y., Che, J., Bao, J., Wang, M., Xu, C., Liu, X., & Shi, Y. (2025) · MedComm · doi:10.1002/mco2.70515 · Cited by 14
Nanomedicine-mediated modulation of tumor metabolism for enhanced immunotherapy
Liu, Y., Sun, D., Li, W., Zhang, Z., Li, C., Che, X., & Zhang, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114587 · Cited by 10
Intranuclear TCA and mitochondrial overload: The nascent sprout of tumors metabolism
Yuan, W., Lu, G., Zhao, Y., He, X., Liao, S., Wang, Z., Lei, X., Xie, Z., Yang, X., Tang, S., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217527 · Cited by 13
Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy
Du, F., Xiao, L., Guojun, W., Dai, Q., Li, J., Zhao, X., Zhang, Q., Yang, L., Liu, Y., Hu, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643017 · Cited by 9
Huggler, K. S., Flickinger, K. M., Forsberg, M. H., Fritz, C. M., Chang, G. R., McGuire, M. F., Capitini, C. M., & Cantor, J. R. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01428-1 · Cited by 10
Comorbidity of hypertension and lung cancer: interplay of genetics and environment
Zeng, J., Shi, D., He, D., Dong, W., Yang, Z., & Chen, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03323-3 · Cited by 8
Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
Zhang, T., Gao, P., & Sun, L. (2025) · MedComm – Oncology · doi:10.1002/mog2.70045 · Cited by 10
Lactate and lactylation in intervertebral disc degeneration
Liu, Y., Yang, J., Wang, Z., Fu, J. H., Liu, H., Lu, Z., Dong, J., Li, Z., Mao, Q., Li, C., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1685975 · Cited by 9
Regulatory T cells in cancer and inflammation
Yang, H., Zhang, H., Xia, N., & Cheng, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02584-w · Cited by 8
Metabolic control of replisome plasticity in genome surveillance
Petersen, M. B., Chhetri, G., & Somyajit, K. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.01.006 · Cited by 7
Li, X., Liu, L., Feng, D., Shi, Y., Huang, L., Yu, M., Fu, X., Deng, L., Nie, X., Chen, C., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00130 · Cited by 8
Tan, Z., Yang, J., Chen, Y., Zhu, H., Liu, X., He, X., Meng, Q., Xiao, M., Tang, R., Rong, Z., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08049-2 · Cited by 7
Li, W.-F., Xu, J., Long, Y., Zhang, H., Rong, X.-J., & Su, Z. (2025) · Genes and Diseases · doi:10.1016/j.gendis.2025.101945 · Cited by 8
Mitochondrial VHL rewires cell metabolism in hypoxia
Li, G., Pan, W., Wu, L., Cai, Z., Chen, H., Wu, X., Yu, T., Liao, K., Zhang, H., 温星桥, et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.11.013 · Cited by 10
Lv, Y., Duan, T., Song, J., Liu, S., Zhou, Z., Ba, Y., Weng, S., Zuo, A., Xu, H., Luo, P., et al. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0002 · Cited by 7
Lactylation and acetylation: parallel paths, divergent deeds, and research dilemmas
Jiang, W., Chen, Y., Lin, S., Liu, Y., & Liao, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07877-w · Cited by 8
Xie, L., Song, D., Ouyang, Z., Ning, Y., Liu, X., Li, L., Xia, W., & Yang, Y. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111585 · Cited by 7
Zhai, J., Fu, R., Luo, S., Liu, X., Xie, Y., Cao, K., Ge, W., & Chen, Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151584 · Cited by 6
Leng, X., Yang, Y., Jiang, T., Zheng, J., Zhang, L., Huang, J., Han, X., Fang, M., Li, X., Wang, Z., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202405174 · Cited by 7
Deletion of ENO1 sensitizes pancreatic cancer cells to gemcitabine via MYC/RRM1-mediated glycolysis
Lu, Y., Ma, H., Xiong, X., Du, Y., Liu, L., Wang, J., & Zhao, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-94319-0 · Cited by 6
Xu, Y., Wang, J., Deng, X., Gao, H., Xing, F., Ding, H., Qu, L., & Xi, Z. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107853 · Cited by 6
Determining the Biological Features of Aggressive Meningioma Growth with Transcriptomic Profiling
Baluszek, S., Kober, P., Myśliwy, I., Oziȩbło, A., Mandat, T. S., Jezewski, M., & Bujko, M. (2025) · Cancers · doi:10.3390/cancers17203324 · Cited by 8
Ji, F., Wang, D., Jin, J., Zhang, J., & Guan, L. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04672-0 · Cited by 6
Liu, N., Ren, X., Guo, W., Huang, L., Tan, L., Wu, Q., Fu, C., Zhang, R., Ye, Y., Wu, L., et al. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.139424 · Cited by 6
The Role of Lactate Metabolism in Tumors
Tian, Z., Zhang, K., Sheng, S., Kan, C., Han, F., & Sun, X. (2025) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001276 · Cited by 7
Energy metabolism, nutrition and cancer
Camajani, E., Gorini, S., Feraco, A., Armani, A., & Caprio, M. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.01.005 · Cited by 6
Tu, M., Deng, X., Zhou, Z., Li, X., Mao, S., Lai, B., Pang, L., Zhong, Q., Cao, J., Liu, H., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04267-8 · Cited by 8
Liang, M.-Z., Huang, X.-F., Zhu, J., Bao, J., Chen, C., Wang, X., Lou, Y.-W., Pan, Y.-T., & Dai, Y. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108507 · Cited by 5
Histone lactylation: A new frontier in laryngeal cancer research (Review)
Tong, Q., Huang, C., Tong, Q., & Zhang, Z. (2025) · Oncology Letters · doi:10.3892/ol.2025.15167 · Cited by 5
Zhou, X., Jiang, J., Liu, J., Wang, Q., Luo, Y., & Wu, L. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1620723 · Cited by 5
BIX01294 suppresses PDAC growth through inhibition of glutaminase-mediated glutathione dynamics
Im, S. S., Seo, J., You, J., Bang, H. W., Kim, Y., Kweon, J., Kim, Y., Shin, D., & Son, J. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102113 · Cited by 4
Yuan, X., Chen, C., Pang, Y., Wang, X., Yang, T., Long, A., Liang, N., Yang, Y., & Li, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1623588 · Cited by 4
Redox‐Active Nanozymes in Metabolic Modulation for Precision Therapeutics
Zhang, W., Wang, M., Ma, P., & Lin, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502110 · Cited by 6
Carrera‐Bastos, P., Muskiet, M. H. A., Ordóñez, F. M., Pruimboom, L., Lucía, A., Luque, R. M., & Muskiet, F. A. J. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09996-z · Cited by 5
Wang, Q., Qiao, H., Yuan, W., Deng, X., Xie, Z., Lei, X., Yang, X., Tang, G., & Wang, Z. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118912 · Cited by 4
Xu, W., Wang, P., Zhu, X., Zhang, Z., Dong, X., An, R., Pang, Q., & Zhang, A. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2610545 · Cited by 4
Zhang, X., Liu, Y., Liu, X., Tan, J., Yuan, L., Wu, W., Li, X., Xi, P., Li, G., & Song, Z. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02218-6 · Cited by 4
Nie, J., Liu, X., Xu, M., Gu, X., Hu, S., Sun, H., Zhou, L., Xu, T., Pan, Y., & Wang, S. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101287 · Cited by 4
The rapamycin sTORy: 50-year journey from Easter Island to the frontiers of biology and medicine
Xiao, X., & Dokudovskaya, S. (2026) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2026.02.004 · Cited by 4
Xiao, L., Na, J., Dang, F., Shao, J., Su, J., Zhong, L., & Zhao, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116586 · Cited by 4
Liu, J. W., Liu, Y., Zhang, H., Li, Z., Fang, X., He, Z., & Bai, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08041-0 · Cited by 4
Metabolites in the extracellular tumor microenvironment and the shaping of macrophage function
Lamorte, S., Bianca, M., Liu, Z. Q., & McGaha, T. L. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.09.016 · Cited by 4
Li, X., Chen, Y., Li, X., Yang, X., Zhou, L., Cheng, Y., Hou, H., Yang, D., Gong, Y., Xiao, H., et al. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01635-9 · Cited by 6
Krkoška, M., Tylichová, Z., Zatloukalová, P., Müller, P., Vojtěšek, B., & Coates, P. J. (2025) · BMC Cancer · doi:10.1186/s12885-025-14460-x · Cited by 3
Du, F., Xu, J., Su, J., Liu, C., Wang, J., Ning, T., Zhang, N., Xu, J., Xie, S.-A., Liu, S., et al. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02281-5 · Cited by 3
Bai, J., Wan, Z., Wu, Z., & Peng, Q. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1683864 · Cited by 3
Li, Z., Liao, J.-L., Luo, M.-R., Fang, S.-J., Huang, W., & Zhang, D.-Y. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.108954 · Cited by 4
Londoño, A. F., Sharma, A., Kathiresan, V., Sealy, J., Volpe, R. P., Gostinčar, C., Pal, U., Dumler, J. S., Hoffman, B. M., & Daly, M. J. (2025) · mBio · doi:10.1128/mbio.02824-25 · Cited by 3
Shi, Y., Zhang, J., Song, B., Zhang, H., He, J., Ding, K., Wang, F., Yu, W., Zhangyuan, G., Jin, K., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03580-8 · Cited by 3
Liu, Y., Yang, X., Qin, M., Chen, W., Liu, C., Jiang, W., Wang, Y., Tan, S., Sun, H., Chen, J., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121554 · Cited by 3
H3K18 lactylation drives CD8+ T cell exclusion and anti-PD-1 resistance in hepatocellular carcinoma
Zhu, J., Dai, X., Luo, T., Zhou, Q., Feng, X., Liu, C., Zhang, B., Yin, B., Wu, P., Luo, R., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117761 · Cited by 3
Lei, B., Zhang, H., Sun, J., Wang, L., Ruan, M., Yan, H., Zhang, A., Chang, C., Yang, H., Huang, G., et al. (2024) · Clinical Lung Cancer · doi:10.1016/j.cllc.2024.11.001 · Cited by 3
Zhang, J., Zhang, S., Yu, F., Wan, Y., Wu, M., & Huang, C. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151613 · Cited by 3
Zhu, L., Feng, L., Han, X., Ye, B., & Xue, L. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70434 · Cited by 3
Zeng, X., Zhang, L., Lu, H., Xue, X., Yang, L., Yang, X., Liu, Z., Cao, X., Dai, Y., & Wei, Z. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70045 · Cited by 3
A primer on metabolic contributions in tumor angiogenic microenvironment
Ocaña, M. C., Bernal, M., Quesada, A. R., & Medina, M. Á. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189417 · Cited by 4
The Impact of IGFBP6 Knockdown on Cholesterol Metabolism in Breast Cancer Cells
Antipenko, I. D., Makarova, J. A., Shkurnikov, M. Y., & Tonevitsky, A. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673396050250729132235 · Cited by 3
Targeting glycolytic enzymes to combat cancer metastasis: Strategies toward clinical translation
Zhang, D., He, Y., & He, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117499 · Cited by 2
Sun, Y., Sun, X. C., Liu, H., & Luo, F. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217412 · Cited by 2
Metadata
- Authors
- Fendt, S.-M.
- Affiliations
- VIB-KU Leuven Center for Cancer Biology (BE)
- Corresponding author
- Fendt, Sarah-Maria
- ORCID
- Fendt, Sarah-Maria
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 187
- Issue
- 15
- Pages
- 3824-3828
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4400978492
- Cited by
- 223
- References
- 53
- Citations by year
- 2026: 116 · 2025: 98 · 2024: 9
- FWCI
- 44.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 389 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Funders
- Stichting Tegen Kanker
- World Cancer Research Fund International (IIG_FULL_2023_001)
- Fonds Baillet Latour
- Fonds Wetenschappelijk Onderzoek
- Gilead Sciences
- Wereld Kanker Onderzoek Fonds
- Australian Research Council
- KU Leuven
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- Warburg effect, Otto Warburg, cancer metabolism, glycolysis, history of cancer research, metabolic reprogramming
- MeSH terms
- Warburg Effect, Oncologic, Animals, Glycolysis, Humans, Neoplasms, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review